{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:57:01Z","timestamp":1776934621270,"version":"3.51.2"},"reference-count":20,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.1080\/14740338.2024.2387309","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T09:18:38Z","timestamp":1722331118000},"page":"977-981","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Central serous chorioretinopathy secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)"],"prefix":"10.1080","volume":"24","author":[{"given":"Chunyan","family":"Zhang","sequence":"first","affiliation":[{"name":"Peking University People\u2019s Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Ren","sequence":"additional","affiliation":[{"name":"Peking University People\u2019s Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Peking University People\u2019s Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Peking University People\u2019s Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking University People\u2019s Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00443-2"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066858"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.09.024"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12779"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1171-5"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-023-00349-y"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-111805"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001833"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1832"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01501.x"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(86)90077-9"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)03392-8"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817323"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0168"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.028"},{"key":"e_1_3_6_18_1","unstructured":"Government of Canada. Health product InfoWatch\u2013November 2019. Balversa\u2122 (erdafitinib). [cited 2021 Oct 19]. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/healthproduct-infowatch\/health-product-infowatch-november-2019.html#a3.2"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.03.025"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.16295\/j.cnki.0257-358x.2022.02.016"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.13444\/j.cnki.zgzyykzz.2020.05.015"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2387309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:16:00Z","timestamp":1776932160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2387309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,3]]}},"alternative-id":["10.1080\/14740338.2024.2387309"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2387309","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}